CONSOLIDATED BALANCE SHEETS - USD ($)	Mar. 31, 2022	Mar. 31, 2021
CURRENT ASSETS
Cash	$ 17,072,419	$ 9,861,575
Accounts receivable	127,965	149,082
Prepaid expenses and other current assets	956,623	341,081
TOTAL CURRENT ASSETS	18,157,007	10,351,738
Property and equipment, net	441,238	160,976
Right-of-use lease asset	696,698	40,363
Patents, net	2,200	56,954
Restricted cash	87,506	46,726
Deposits	33,305	12,159
TOTAL ASSETS	19,417,954	10,668,916
CURRENT LIABILITIES
Accounts payable	499,962	337,678
Due to related parties	155,742	118,520
Deferred revenue	344,547	114,849
Lease liability, current portion	126,905	42,543
Other current liabilities	696,893	761,636
TOTAL CURRENT LIABILITIES	1,824,049	1,375,226
Lease liability, less current portion	602,505	0
TOTAL LIABILITIES	2,426,554	1,375,226
STOCKHOLDERS’ EQUITY
Common stock, $0.001 par value, 30,000,000 shares authorized at March 31, 2022 and 2021; 15,419,163 and 12,150,597 issued and outstanding at March 31, 2022 and 2021, respectively	15,421	12,152
Additional paid-in capital	147,446,868	129,331,542
Accumulated deficit	(130,329,181)	(119,913,090)
TOTAL AETHLON MEDICAL, INC. STOCKHOLDERS’ EQUITY BEFORE NONCONTROLLING INTERESTS	17,133,108	9,430,604
NONCONTROLLING INTERESTS	(141,708)	(136,914)
TOTAL STOCKHOLDERS’ EQUITY	16,991,400	9,293,690
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	$ 19,417,954	$ 10,668,916